Drug Search Results
More Filters [+]

SPH-7854

Alternative Names: SPH-7854, SPH 7854, SPH7854
Latest Update: 2024-07-02
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Shanghai Holding
Company Location: NEW YORK NY 10271
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for SPH-7854

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Healthy Volunteers|Inflammatory Bowel Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

SPH7854-101

P1

Recruiting

Inflammatory Bowel Diseases

2025-12-31

CTR20242096

P1

Recruiting

Healthy Volunteers

None

Recent News Events

Date

Type

Title